title: Malignant gliomas.
abstract: Malignant gliomas are the most common type of primary brain tumor. Although therapy for patients with these tumors remains limited, there has been important progress recently. In this review, some of these advances are discussed, with an emphasis on targeted molecular therapies.
authors.affiliation: Center for Neuro-Oncology, Dana Farber Cancer Institute, SW430D, 44 Binney Street, Boston, MA 02115, USA. pwen@partners.org
authors.forename: Patrick Y
authors.initials: PY
authors.lastname: Wen
authors.forename: Santosh
authors.initials: S
authors.lastname: Kesari
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D015316:Genetic Therapy; D005910:Glioma / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans
chemical_list: D000970:Antineoplastic Agents